Effects of low-calorie balanced diet containing wholegrain bread and wholegrain rice on indicators of metabolic syndrome

Effects of low-calorie balanced diet containing wholegrain bread and wholegrain rice on indicators of metabolic syndrome in obese and overweight patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015062422905N1

Enrollment

Registered

2016-09-25

Start date

2015-07-06

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Obesity. Condition 2: Diabetes. Condition 3: Hypertension. Condition 4: Hyperlipidaemia. Obesity due to excess calories Non-insulin-dependent diabetes mellitus Secondary hypertension Disorders of lipoprotein metabolism and other lipidaemias

Interventions

Intervention 1: Intervention group:200 gram wholemeal bread and 100 gram wholegrain rice with a balanced low calorie diet for 12 weeks. Intervention 2: control Group: bread and white rice with a balan

Treatment - Other

Intervention group:200 gram wholemeal bread and 100 gram wholegrain rice with a balanced low calorie diet for 12 weeks.

control Group: bread and white rice with a balanced low calorie diet for 12 weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: At least three of the indicators have metabolic syndrome include: Abdominal obesity; High blood sugar; High blood fat; Blood pressure; People with obesity and overweight (BMI greater than 25); Willingness to cooperate Exclusion: Disease leading to hospitalization or discharge from the hospital; The person is under a special regime; Pregnant and lactating women; Professional athletes; People with type 1 diabetes

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Waist circumference. Timepoint: Early intervention, Fourth Week, Eight Week, End of intervention. Method of measurement: by meter.centimeter.;Fasting blood sample. Timepoint: The beginning and end of the intervention. Method of measurement: measured by enzymatic spectrophotometry analysis.basiis mg/dl.;Blood pressure. Timepoint: Early intervention, Fourth Week, Eight Week, End of intervention. Method of measurement: mmHg,with an automatic sphygmomanometer.;Lipid profile. Timepoint: The beginning and end of the intervention. Method of measurement: measured by enzymatic spectrophotometry analysis.basis mg/dl.;Weight. Timepoint: Early intervention, Fourth Week, Eight Week,End of intervention. Method of measurement: scales Seca (made in Germany) and 1.0 kg accuracy.basis kg.	—

Measure

Time frame

Waist circumference. Timepoint: Early intervention, Fourth Week, Eight Week, End of intervention. Method of measurement: by meter.centimeter.;Fasting blood sample. Timepoint: The beginning and end of the intervention. Method of measurement: measured by enzymatic spectrophotometry analysis.basiis mg/dl.;Blood pressure. Timepoint: Early intervention, Fourth Week, Eight Week, End of intervention. Method of measurement: mmHg,with an automatic sphygmomanometer.;Lipid profile. Timepoint: The beginning and end of the intervention. Method of measurement: measured by enzymatic spectrophotometry analysis.basis mg/dl.;Weight. Timepoint: Early intervention, Fourth Week, Eight Week,End of intervention. Method of measurement: scales Seca (made in Germany) and 1.0 kg accuracy.basis kg.

—

Secondary

Measure	Time frame
Body mass index. Timepoint: The beginning and end of the intervention. Method of measurement: Measured height and weight.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMusa Salehi

Shiraz University of Medical Sciences

Salehi@sums.ac.ir+98 71 3725 1001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026